title: Rituximab for the treatment of high titre inhibitors in mild haemophilia A.
authors.affiliation: Department of Oncology and Haematology, Division of Paediatrics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
authors.forename: Majda Benedik
authors.initials: MB
authors.lastname: Dolničar
authors.affiliation: Department of Oncology and Haematology, Division of Paediatrics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
authors.forename: Vladan
authors.initials: V
authors.lastname: Rajić
authors.affiliation: Department of Oncology and Haematology, Division of Paediatrics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
authors.forename: Lidija
authors.initials: L
authors.lastname: Kitanovski
authors.affiliation: Unit for Special Laboratory Diagnostics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
authors.forename: Maruša
authors.initials: M
authors.lastname: Debeljak
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001064:Appendicitis / Q000150:complications / Q000601:surgery; D001402:B-Lymphocytes; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005169:Factor VIII / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007518:Isoantibodies / Q000097:blood* / Q000276:immunology; D018655:Lymphocyte Count; D008297:Male; D020125:Mutation, Missense; D010538:Peritonitis / Q000209:etiology / Q000601:surgery; D019106:Postoperative Hemorrhage / Q000188:drug therapy / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000933:Antifibrinolytic Agents; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D011994:Recombinant Proteins; D000069283:Rituximab; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa; D003894:Deamino Arginine Vasopressin